AC
TMO icon

AKO Capital’s Thermo Fisher Scientific TMO Stock Holding History

AKO Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26,427
Closed -$10.7M – 26
2025
Q2 		$10.7M Sell
26,427
-306,418
-92% -$128M 0.14% 23
2025
Q1 		$166M Buy
332,845
+19,061
+6% +$10.3M 2.15% 20
2024
Q4 		$163M Sell
313,784
-109,689
-26% -$60.3M 2.26% 20
2024
Q3 		$262M Sell
423,473
-100,775
-19% -$59.7M 3.41% 16
2024
Q2 		$290M Buy
524,248
+64,065
+14% +$36.7M 3.98% 12
2024
Q1 		$267M Buy
460,183
+296,246
+181% +$166M 3.79% 14
2023
Q4 		$87M Sell
163,937
-174,490
-52% -$84.5M 1.24% 26
2023
Q3 		$171M Sell
338,427
-7,146
-2% -$3.81M 2.79% 16
2023
Q2 		$180M Sell
345,573
-268,711
-44% -$145M 2.73% 17
2023
Q1 		$354M Sell
614,284
-33,059
-5% -$18.6M 5.39% 7
2022
Q4 		$356M Sell
647,343
-276,688
-30% -$147M 5.76% 6
2022
Q3 		$469M Sell
924,031
-288,469
-24% -$161M 7.73% 3
2022
Q2 		$659M Buy
1,212,500
+5,962
+0.5% +$3.28M 9.23% 1
2022
Q1 		$713M Sell
1,206,538
-23,361
-2% -$13.4M 7.69% 3
2021
Q4 		$821M Buy
1,229,899
+87,438
+8% +$54.6M 7.99% 4
2021
Q3 		$653M Buy
1,142,461
+158,024
+16% +$86.7M 6.76% 4
2021
Q2 		$497M Buy
984,437
+248,578
+34% +$117M 5.6% 5
2021
Q1 		$336M Buy
735,859
+206,585
+39% +$98.6M 4.15% 9
2020
Q4 		$247M Buy
529,274
+93,897
+22% +$44M 3.18% 15
2020
Q3 		$192M Buy
+435,377
New +$180M 3.02% 16

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AKO Capital's TMO Position: Q3 2025 in Review

AKO Capital sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 26,427 shares — an estimated $10.7M sold.

AKO Capital first reported a position in TMO in Q3 2020 and held it in 20 quarters. The position peaked at $821M in Q4 2021. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • AKO Capital reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • AKO Capital sold 26,427 Thermo Fisher Scientific shares in Q3 2025, an estimated $10.7M.
  • AKO Capital first reported a position in Thermo Fisher Scientific in Q3 2020 and held it in 20 quarters.
  • AKO Capital's Thermo Fisher Scientific position peaked at $821M in Q4 2021.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on AKO Capital's 13F filing for Q3 2025, filed 13 Nov 2025.